Indeed, MEC tumor cell lines expressing p21 (Figure 3B) failed to activate senescence (Figure 3C), as measured by p16ink4 levels, in basal conditions and following administration of Emetine, suggesting that p21 acts as an oncogene in MEC, as it does in other cancers. This evidence concerns the gene CDKN2A and cancer.